Resumption of Sales Activities and Expense Review Amid Infection-Control Measures
First written in FY2020. 2 of 4 entries say "Restated". Latest entry: FY2023-Q1.
The whole theme swung hardest in 2025: 2 of 11 companies on the "Worse" side.
38 other companies' latest entry also says "Restated".
- FY2023-Q1RestatedAnnual report
「In addition, factors such as the continued implementation of infection-control measures related to COVID-19, the situation in Ukraine, utility costs and prices associated with the weaker yen, and concerns over rising interest rates may affect consumer sentiment.」
The impact on the business environment is described on the assumption that measures to prevent infection amid the coronavirus pandemic will continue. - FY2022RestatedAnnual report
「The Group will continue to implement thorough infectious disease countermeasures and seek to maintain and expand its business results while making use of new sales methods suited to the coronavirus pandemic.」
The Company continues to state its policy of maintaining and expanding business results by continuing infectious disease countermeasures and using new sales methods. - FY2021-Q1AdvancedAnnual report
「With the spread of COVID-19, customer visits were forced to decline substantially as a result of reduced business hours, voluntary suspension of sales visits and work-from-home arrangements, among other measures. However, visits have gradually begun to recover since the state of emergency was lifted.」
The Company has stated that, amid the spread of infectious disease, it implemented specific measures including reduced business hours, suspension of visits, and remote working, and that customer visits have gradually recovered since the lifting of the state of emergency. - FY2020First statedAnnual report
「The Group will fully resume sales activities while implementing infectious disease countermeasures and review expenses and other costs.」
The Company has stated a policy of resuming sales activities while implementing infectious disease countermeasures and reviewing expenses in response to the decline in customer visits.